Monotherapy - PowerPoint PPT Presentation


Ticagrelor Monotherapy vs. 12-Month Dual Anti-Platelet Therapy After Coronary Stent Implantation for ACS

The study compares the efficacy of ticagrelor monotherapy after less than 1 month of dual anti-platelet therapy (DAPT) to 12-month ticagrelor-based DAPT in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with drug-eluting stent implantation. The aim is

1 views • 19 slides


Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in High-Risk PCI Patients: TWILIGHT-COMPLEX Study

Patients undergoing complex PCI are at high risk of ischemic events. The TWILIGHT-COMPLEX study aims to compare the safety and efficacy of ticagrelor monotherapy versus ticagrelor with aspirin in patients who completed 3 months of DAPT post-PCI. While extended DAPT may reduce ischemic events, it als

0 views • 27 slides



DTG Monotherapy in Early HIV-1 Infection: Study Overview

Study investigating the efficacy of dolutegravir (DTG) monotherapy in early HIV-1 infection showed non-inferiority compared to standard combination antiretroviral therapy (cART). The EARLY-SIMPLIFIED study involved 68 patients on DTG monotherapy and 33 on cART, with both groups achieving HIV RNA sup

0 views • 6 slides